Kerberos Proximal Solutions Inc.

Kerberos Proximal Solutions Inc., was founded to develop a proximal embolic-protection technology to recover debris dislodged during angioplasty and stent placement. Kerberos launched its lead product for coronary and peripheral use under the Rinspiration System™.

FoxHollow Technologies (Nasdaq: FOXH) acquired Kerberos for $13 million and up to an additional $19 million in future milestones.

Investors

• Research Corporation Technoologies, Inc.
• Boston Scientific

Inventors/Founders

• John MacMahon, President, Chief Executive Officer
• Thomas Goff, Chief Design Engineer